Additionally, direct activation of TRPA1 using optopharmacology and chemogenetic methods attenuates TNF production, whereas deletion of TRPA1 or interrupting afferent vagus nerve signaling results in a loss of these anti-inflammatory effects and decreases survival from infection. The gene discussed is TNF; the disease is infection.